xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

684

International consensus statement on rhinosinusitis

834. Boita MM, Garzaro MM, Raimondo LL, et al. The expression of TSLP receptor in chronic rhinosinusitis with and without nasal polyps. Int J Immunopathol Pharmacol . 2011;24(3):761. 835. Kern RC, Conley DB, Walsh W, et al. Perspectives on the etiol ogy of chronic rhinosinusitis: an immune barrier hypothesis. AmJRhinol . 2008;22(6):549-559. 836. Kong IG, Kim DW. Pathogenesis of recalcitrant chronic rhinosinusitis: the emerging role of innate immune cells. Immune Netw . 2018;18(2):e6. 837. Kato K, Song BH, Howe CL, Chang EH. A comprehensive sys tematic review of the association between airway mucins and chronic rhinosinusitis. Am J Rhinol Allergy . 2019;33(4):433 448. 838. Kim DH, Chu HS, Lee JY, Hwang SJ, Lee SH, Lee HM. Up-regulation of MUC5AC and MUC5B mucin genes in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg . 2004;130(6):747-752. 839. Martinez-Anton A, Debolos C, Garrido M, et al. Mucin genes have different expression patterns in healthy and diseased upper airway mucosa. Clin Exp Allergy . 2006;36(4):448-457. 840. Cutting GR. Modifier genetics: cystic fibrosis. Annu Rev Genomics Hum Genet . 2005;6:237-260. 841. Antunes MB, Gudis DA, Cohen NA. Epithelium, cilia, and mucus: their importance in chronic rhinosinusitis. Immunol Allergy Clin North Am . 2009;29(4):631-643. 842. Chen B, Antunes MB, Claire SE, et al. Reversal of chronic rhinosinusitis-associated sinonasal ciliary dysfunction. AmJ Rhinol . 2007;21(3):346-353. 843. Saito DM, Innes AL, Pletcher SD. Rheologic properties of sinonasal mucus in patients with chronic sinusitis. AmJRhi nol Allergy . 2010;24(1):1-5. 844. Heffler E, Malvezzi L, Boita M, et al. Immunological mech anisms underlying chronic rhinosinusitis with nasal polyps. Expert Rev Clin Immunol . 2018;14(9):731-737. 845. Mitson-Salazar A, Prussin C. Pathogenic effector Th2 cells in allergic eosinophilic inflammatory disease. Front Med (Lau sanne) . 2017;4:165. 846. Stevens WW, Lee RJ, Schleimer RP, Cohen NA. Chronic rhinosinusitis pathogenesis. J Allergy Clin Immunol . 2015;136(6):1442-1453. 847. Den Beste KA, Hoddeson EK, Parkos CA, Nusrat A, Wise SK. Epithelial permeability alterations in an in vitro air-liquid interface model of allergic fungal rhinosinusitis. Int Forum Allergy Rhinol . 2013;3(1):19-25. 848. Pothoven KL, Norton JE, Hulse KE, et al. Oncostatin M pro motes mucosal epithelial barrier dysfunction, and its expres sion is increased in patients with eosinophilic mucosal dis ease. J Allergy Clin Immunol . 2015;136(3):737-746.e734. 849. Soyka MB, Wawrzyniak P, Eiwegger T, et al. Defective epithe lial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4. J Allergy Clin Immunol . 2012;130(5):1087-1096 e1010. 850. Zhao L, Li YY, Li CW, et al. Increase of poorly prolifer ated p63( + ) /Ki67( + ) basal cells forming multiple layers in the aberrant remodeled epithelium in nasal polyps. Allergy . 2017;72(6):975-984. 851. Toskala E, Nuutinen J, Rautiainen M. Scanning electron microscopy findings of human respiratory cilia in chronic

817. Huang Z, Nayak JV, Sun Y, Huang Q, Zhou B. Peripheral blood T-helper cells and eosinophil populations in patients with atopic and nonatopic chronic rhinosinusitis. AmJ Rhi nol Allergy . 2017;31(1):8. 818. Takahashi T, Kato A, Berdnikovs S, et al. Microparticles in nasal lavage fluids in chronic rhinosinusitis: potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol . 2017;140(3):720-729. 819. Sejima T, Holtappels G, Kikuchi H, Imayoshi S, Ichimura K, Bachert C. Cytokine profiles in Japanese patients with chronic rhinosinusitis. Allergol Int . 61(1):115-122. 820. Cao PP, Li HB, Wang BF, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol .124(3):478-484.e472. 821. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy . 2006;61(11):1280-1289. 822. Shaw JL, Ashoori F, Fakhri S, Citardi MJ, Luong A. Increased percentage of mast cells within sinonasal mucosa of chronic rhinosinusitis with nasal polyp patients independent of atopy. Int Forum Allergy Rhinol . 2012;2(3):233-240. 823. Takabayashi T, Kato A, Peters AT, et al. Glandular mast cells with distinct phenotype are highly elevated in chronic rhinos inusitis with nasal polyps. J Allergy Clin Immunol . 130(2):410 420.e415. 824. Mahdavinia M, Carter RG, Ocampo CJ, et al. Basophils are elevated in nasal polyps of patients with chronic rhinosi nusitis without aspirin sensitivity. J Allergy Clin Immunol . 2014;133(6):1759-1763. 825. Park SK, Jin YD, Park YK, et al. IL-25-induced activation of nasal fibroblast and its association with the remodeling of chronic rhinosinusitis with nasal polyposis. PLoS One . 2017;12(8):e0181806. 826. Carroll WW, O’Connell BP, Schlosser RJ, et al. Fibroblast lev els are increased in chronic rhinosinusitis with nasal polyps and are associated with worse subjective disease severity. Int Forum Allergy Rhinol . 2016;6(2):162-168. 827. Oyer SL, Nagel W, Mulligan JK. Differential expression of adhesion molecules by sinonasal fibroblasts among control and chronic rhinosinusitis patients. Am J Rhinol Allergy . 2013;27(5):381-386. 828. Ozturan A, Eyigor H, Eyigor M, et al. The role of IL-25 and IL 33 in chronic rhinosinusitis with or without nasal polyps. Eur Arch Otorhinolaryngol . 2017;274(1):283-288. 829. Xu J, Han R, Kim DW, et al. Role of Interleukin-10 on nasal polypogenesis in patients with chronic rhinosinusitis with nasal polyps. PLoSOne . 2016;11(9):e0161013. 830. Shin HW KD, Park MH, Eun KM, et al. IL-25 as a novel ther apeutic target in nasal polyps of patients with chronic rhinos inusitis. J Allergy Clin Immunol . 2015(135):6. 831. Lam M, Hull L, McLachlan R, Md KS, Md RJH. Clinical severity and epithelial endotypes in chronic rhinosinusitis. Int Forum Allergy Rhinol . 2013;3(2):121-128. 832. Kim DK, Jin HR, Eun KM, et al. The role of interleukin-33 in chronic rhinosinusitis. Thorax . 2017;72(7):635-645. 833. Nagarkar DR, Poposki JA, Tan BK, et al. Thymic stromal lym phopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol . 132(3):593 600.e512.